ACS CAN comments on Most Favored Nation Rule
On Tuesday, January 19, ACS CAN submitted comments in response to the Most Favored Nation (MFN) interim final rule with comments.
Cancer patients and survivors in Medicare rely on drug therapies for lifesaving treatments. Therefore, it is paramount that any new Medicare payment model that seeks to reduce spending on prescription drugs not impede beneficiary access to lifesaving treatments. Unfortunately, we believe that the MFN Model could actually make it harder for cancer patients to access the drugs they need.